Drug intelligence / Profile preview

rabies vaccine (Shanghai Rongsheng Biopharmaceutical)

Development stage
Approved
Lead developer
Shanghai Rongsheng Biopharmaceutical
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Wuxueqing refers to the serum-free rabies vaccine (Vero cell) developed and manufactured by Shanghai Rongsheng Biopharmaceutical. This vaccine is produced using advanced serum-free cell culture technology, which eliminates the use of animal-derived serum (such as bovine serum) during the cultivation of the rabies fixed virus in Vero cells. This manufacturing approach is designed to enhance product safety by minimizing the risk of allergic reactions to residual animal proteins and reducing the potential for contamination with adventitious agents. The vaccine contains inactivated rabies virus (typically the Pitman-Moore strain) and is indicated for both pre-exposure and post-exposure prophylaxis against rabies. It works by stimulating the host's immune system to produce neutralizing antibodies that target the rabies virus glycoprotein, thereby providing active immunity against the pathogen.

Brand names
Wuxueqing
Other names
rabies vaccine (Vero cell, serum-free)无血清狂犬疫苗Freeze-dried Rabies Vaccine (Vero Cell, Serum-free)

Beyond the preview

Go deeper on rabies vaccine (Shanghai Rongsheng Biopharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies vaccine (Shanghai Rongsheng Biopharmaceutical).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call